Raxibacumab FDA Approval History
FDA Approved: Yes (First approved December 14, 2012)
Generic name: raxibacumab
Company: Emergent BioSolutions Inc.
Treatment for: Anthrax
Raxibacumab is a human monoclonal antibody drug for the treatment of inhalational anthrax.
Development timeline for raxibacumab
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.